Omeros (OMER)
(Delayed Data from NSDQ)
$4.87 USD
-0.15 (-2.99%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $4.85 -0.02 (-0.41%) 5:18 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 36% (90 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.69 | 9.99 |
Current Quarter Estimate | NA | 5.88 | 61.00 |
Year Ago Quarter Estimate | -0.70 | 4.88 | 54.84 |
Next Quarter Estimate | NA | 7.06 | 63.00 |
Next Year Estimate | NA | 39.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 35.13 | 12.40 | 15.67 |
Next Year | NA | 26.10 | 11.34 |
Last 5 Years | -321.70 | 3.70 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | NA | 2.05 |
Price/Cash Flow (MRFY) | NA | 10.98 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 11.36% |
Return on Equity (TTM) | -1,916.35% | 13.81% |
Debt to Equity (MRQ) | NA | 32.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.